Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. V. Jensen · SciRah

Researcher profile · Semantic Scholar

N. V. Jensen

Share profile

N. V. Jensen — researcher profile on SciRah

h-index: 11
Works: 29
Citations: 475

Most-cited papers

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
D. McDermott, Jae-Lyun Lee, G. Bjarnason, J. Larkin +16 more
2021Journal of Clinical Oncology107 citations Open access
Semantic Scholar
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
D. Petrylak, R. de Wit, K. Chi, A. Drakaki +142 more
2019The Lancet Oncology78 citations Open access
Semantic Scholar
Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2.
A. V. Soerensen, F. Donskov, G. Hermann, N. V. Jensen +5 more
2014European Journal of Cancer75 citations Open access
Semantic Scholar
Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
F. Donskov, R. Motzer, E. Voog, E. Hovey +15 more
2019European Journal of Cancer28 citations Open access
Semantic Scholar
Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM).
K. Holmsten, N. V. Jensen, L. Mouritsen, E. Jonsson +13 more
2020European Journal of Cancer22 citations Open access
Semantic Scholar
Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
L. H. Omland, H. Lindberg, A. Carus, A. Als +6 more
2020European Urology Open Science22 citations Open access
Semantic Scholar
Trends in kidney cancer among the elderly in Denmark, 1980–2012
N. Azawi, S. M. Joergensen, N. V. Jensen, P. Clark +1 more
2016Acta oncologica16 citations Open access
Semantic Scholar
A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1
F. Donskov, N. V. Jensen, T. Smidt-Hansen, Line Brøndum +1 more
2018Acta oncologica15 citations Open access
Semantic Scholar
Vinflunine treatment in patients with metastatic urothelial cancer: A Nordic retrospective multicenter analysis
K. Holmsten, L. Dohn, N. V. Jensen, C. Shah +3 more
2016Oncology Letters15 citations Open access
Semantic Scholar
A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
A. V. Soerensen, P. Geertsen, I. Christensen, G. Hermann +5 more
2015Acta oncologica15 citations Open access
Semantic Scholar
[Palliative medicine education].
L. Pedersen, A. B. Jensen, B. Enig, P. Hansen +4 more
2002Ugeskrift for læger14 citations
Semantic Scholar
Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites
A. Tinning, Camilla Bengtsen, N. V. Jensen, L. Bastholt +2 more
2018HYPERTENSION11 citations Open access
Semantic Scholar
Trends in cancer of the urinary bladder and urinary tract in elderly in Denmark, 2008–2012
T. K. Jensen, N. V. Jensen, Simon Møller Jørgensen, P. Clark +1 more
2016Acta oncologica10 citations Open access
Semantic Scholar
Combination of docetaxel and gemcitabine in the treatment of advanced non-small cell lung cancer (NSCLC)
N. V. Jensen, O. Hansen, C. Rose
199910 citations
Semantic Scholar
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer
Trine Zeeberg Buch-Hansen, L. Bentzen, S. Hansen, M. Hoeyer +3 more
2010Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark
L. H. Omland, D. Stormoen, L. Dohn, A. Carus +5 more
2021Bladder Cancer7 citations Open access
Semantic Scholar
Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen
K. Holmsten, L. H. Omland, A. Als, M. Agerbæk +9 more
2021Bladder Cancer7 citations Open access
Semantic Scholar
A randomized phase II trial of interleukin-2/interferon-α plus bevacizumab versus interleukin-2/interferon-α in metastatic renal cell carcinoma (mRCC): Results from the Danish Renal Cancer Group (DARENCA) study 1.
F. Donskov, N. V. Jensen, T. Smidt-Hansen, Line Brøndum +1 more
20166 citations
Semantic Scholar
Implementation of Targeted Therapy in Denmark for Patients with Metastatic Renal Cell Carcinoma: Results from the Danish Renal Cancer Group (DARENCA) Study-2
A. V. Soerensen, F. Donskov, G. Hermann, N. V. Jensen +4 more
20124 citations Open access
Semantic Scholar
Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in patients with advanced renal cell carcinoma (RCC).
F. Donskov, R. Motzer, E. Voog, E. Hovey +15 more
20173 citations
Semantic Scholar
First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A.
D. McDermott, Jae-Lyun Lee, G. Bjarnason, J. Larkin +16 more
2020Journal of Clinical Oncology2 citations Open access
Semantic Scholar
The Danish Bladder Cancer Database: Three years follow-up
E. Hansen, H. Larsson, M. Nørgaard, A. P. Pilt +4 more
20180 citations
Semantic Scholar
University of Southern Denmark A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC)
F. Jensen, Niels Viggo Smidt-Hansen, T. Brondum, F. Donskov +4 more
20180 citations
Semantic Scholar
A multicenter, randomized phase II trial of vinflunine and gemcitabine versus carboplatin and gemcitabine as first line treatment in patients with metastatic urothelial carcinoma unfit for cisplatin based chemotherapy due to impaired renal function-VINGEM
K. Holmsten, N. V. Jensen, L. Mouritsen, M. Agerbæk +14 more
20170 citations
Semantic Scholar
Urological Survey Geriatrics Re : Efficacy and Safety of Axitinib in Elderly Patients with Metastatic Renal Cell Carcinoma
H. Miyake, K. Harada, S. Ozono, M. Fujisawa +5 more
20160 citations
Semantic Scholar
103 Cancer of the kidney in elderly in Denmark, 2008–2012
N. Azawi, S. M. Joergensen, N. V. Jensen, L. Lund
20150 citations
Semantic Scholar
819PHYPERTENSION, NEUTROPENIA, THROMBOCYTOPENIA, NORMAL SODIUM AND LDH WITHIN THE FIRST 12 WEEKS OF TREATMENT AS INDEPENDENT BIOMARKERS OF OUTCOME IN METASTATIC RENAL CELL CARCINOMA (MRCC).
A. V. Soerensen, P. Geertsen, I. Christensen, G. G. Hermann +5 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
P017 Vinflunine as second line chemotherapy for patients with metastatic urothelial cancer – A Nordic multi-center retrospective study
Karin Holmsten, L. Dohn, N. V. Jensen, C. Shah +2 more
20130 citations
Semantic Scholar
P-9 Economic analysis of patients in performance status 0–1 versus performance status 2 treated with carboplatin or carboplatin plus taxotere for NSCLC stage IIIb or IV
N. V. Jensen, Janne Baekke, O. Hansen
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Donskov×11
Invite
F. Donskov — researcher profile on SciRah
P. Geertsen×9
Invite
P. Geertsen — researcher profile on SciRah
H. Pappot×7
Invite
H. Pappot — researcher profile on SciRah
A. Ullén×5
Invite
A. Ullén — researcher profile on SciRah

A. V. Soerensen

×4

Invite

A. V. Soerensen — researcher profile on SciRah

Invite

K. Holmsten — researcher profile on SciRah

Invite

A. Carus — researcher profile on SciRah

Invite

L. Lund — researcher profile on SciRah

Invite

L. Dohn — researcher profile on SciRah

Jae-Lyun Lee×3

Invite

Jae-Lyun Lee — researcher profile on SciRah

Invite

T. Powles — researcher profile on SciRah

Invite

G. Hermann — researcher profile on SciRah